WallStreetZenWallStreetZen

NASDAQ: NRSN
Neurosense Therapeutics Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

NRSN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$11.3M
Current Profit Margin
0%

NRSN Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when NRSN announces earnings.

NRSN Return on Assets

Current Company
-207.3%
Current Industry
2.9%
NRSN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NRSN Return on Capital Employed

Current Company
3,205.3%
Current Industry
19.5%
NRSN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NRSN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NRSN$0.00-$8.97M-$11.28MN/AN/A
BIVI$0.00-$39.04M-$43.27MN/AN/A
VINC$0.00-$39.24M-$40.16MN/AN/A
AKTX$0.00-$10.00M-$10.01MN/AN/A
INDP$0.00-$15.42M-$15.42MN/AN/A
View Top Biotech Stocks

NRSN earnings dates

Next earnings date
May 25, 2024

Neurosense Therapeutics Earnings & Revenue FAQ

What were NRSN's earnings last quarter?

On Invalid Date, Neurosense Therapeutics (NASDAQ: NRSN) reported Q4 2023 earnings per share (EPS) of -$0.16, up 40.74% year over year. Total Neurosense Therapeutics earnings for the quarter were -$2.95 million. In the same quarter last year, Neurosense Therapeutics's earnings per share (EPS) was -$0.27.

If you're new to stock investing, here's how to buy Neurosense Therapeutics stock.

What was NRSN's earnings growth in the past year?

As of Q2 2024, Neurosense Therapeutics's earnings has grown year over year. Neurosense Therapeutics's earnings in the past year totalled -$11.28 million.

What is NRSN's earnings date?

Neurosense Therapeutics's earnings date is Invalid Date. Add NRSN to your watchlist to be reminded of NRSN's next earnings announcement.

What was NRSN's revenue last quarter?

On Invalid Date, Neurosense Therapeutics (NASDAQ: NRSN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Neurosense Therapeutics's revenue was $0.00.

What was NRSN's revenue growth in the past year?

As of Q2 2024, Neurosense Therapeutics's revenue has grown null year over year. Neurosense Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.